Etilamfetamine

Jump to navigation Jump to search
Etilamfetamine
Ball-and-stick model of etilamfetamine molecule
Clinical data
Routes of
administration
Oral, Sublingual, Insufflated (Snorted), Inhaled (Vaporized), Intravenous, Rectal
ATC code
Legal status
Legal status
  • Schedule 1
Pharmacokinetic data
MetabolismHepatic
ExcretionRenal
Identifiers
CAS Number
PubChem CID
ChemSpider
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC11H17N
Molar mass163.259 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Etilamfetamine

Articles

Most recent articles on Etilamfetamine

Most cited articles on Etilamfetamine

Review articles on Etilamfetamine

Articles on Etilamfetamine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Etilamfetamine

Images of Etilamfetamine

Photos of Etilamfetamine

Podcasts & MP3s on Etilamfetamine

Videos on Etilamfetamine

Evidence Based Medicine

Cochrane Collaboration on Etilamfetamine

Bandolier on Etilamfetamine

TRIP on Etilamfetamine

Clinical Trials

Ongoing Trials on Etilamfetamine at Clinical Trials.gov

Trial results on Etilamfetamine

Clinical Trials on Etilamfetamine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Etilamfetamine

NICE Guidance on Etilamfetamine

NHS PRODIGY Guidance

FDA on Etilamfetamine

CDC on Etilamfetamine

Books

Books on Etilamfetamine

News

Etilamfetamine in the news

Be alerted to news on Etilamfetamine

News trends on Etilamfetamine

Commentary

Blogs on Etilamfetamine

Definitions

Definitions of Etilamfetamine

Patient Resources / Community

Patient resources on Etilamfetamine

Discussion groups on Etilamfetamine

Patient Handouts on Etilamfetamine

Directions to Hospitals Treating Etilamfetamine

Risk calculators and risk factors for Etilamfetamine

Healthcare Provider Resources

Symptoms of Etilamfetamine

Causes & Risk Factors for Etilamfetamine

Diagnostic studies for Etilamfetamine

Treatment of Etilamfetamine

Continuing Medical Education (CME)

CME Programs on Etilamfetamine

International

Etilamfetamine en Espanol

Etilamfetamine en Francais

Business

Etilamfetamine in the Marketplace

Patents on Etilamfetamine

Experimental / Informatics

List of terms related to Etilamfetamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ethylamphetamine (Apetinil, Adiparthrol), also known as etilamfetamine (INN) or N-ethylamphetamine, is a stimulant drug of the phenethylamine and amphetamine chemical classes. It was invented in the early 20th century and was subsequently used as an anorectic or appetite suppressant in the 1950s,[1] but was not as commonly used as other amphetamines such as amphetamine, methamphetamine, and benzphetamine, and was largely discontinued once newer drugs such as phenmetrazine were introduced.

Chemistry

The molecular structure of ethylamphetamine is analogous to amphetamine's.[Note 1] It is a substituted amphetamine, with an ethyl group on the amphetamine backbone.[Note 2][Note 3]

Recreational use

Ethylamphetamine can be used as a recreational drug and, while its prevalence is less than amphetamine's, it is still encountered as a substance taken for recreational purposes.

Ethylamphetamine produces effects similar to amphetamine and methamphetamine, its potency being slightly greater than amphetamine's and lesser than methamphetamine's.[Note 4][Note 5]

See also

References

  1. PMID 13389142 (PMID 13389142)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

Notes

  1. Amphetamine is a substituted phenethylamine with a methyl group at RA position.
  2. The ethyl group of ethylamphetamine is at RN position, hence the name N-ethylamphetamine.
  3. Ethylamphetamine is structurally similar to N-methylamphetamine (methamphetamine), the ethyl group being replaced in methamphetamine with a methyl group.
  4. Ethylamphetamine's higher potency may make its risk of causing abuse, dependence and/or addiction greater compared to amphetamine.
  5. A cohort of Australian users in the 1990s found single 40 mg doses of commercially produced racemic ethylamphetamine hydrochloride substantially less effective recreationally than 40 mg doses of either racemic amphetamine sulphate, d-methylamphetamine hydrochloride or racemic fenethylline hydrochloride.

Template:Stimulants Template:Anorectics Template:Catecholaminergics Template:Phenethylamines